We propose that during HCC progression in DEN-treated mice, NK cells and NKT cells, via NKG2D, are likely to act as the main effectors against early neoplasia, although falling short of complete tumor elimination. This evidence concerns the gene KLRK1 and hepatocellular carcinoma.